https://www.selleckchem.com/pr....oducts/talabostat.ht
Vaginal delivery is the most common reason for hospitalization in the United States, and approximately 30% of women fill an opioid prescription after vaginal delivery, making this a common source of opioid exposure in women of reproductive age. This study aimed to evaluate the effect of receiving an opioid prescription after vaginal delivery on the risk of subsequent persistent opioid use, opioid use disorders, and overdose. We assembled a nationwide cohort of Medicaid beneficiaries in the United States using the Medicaid Analytic eX
Like
Comment
Share
